Hongyun Zhao

Hongyun is a senior scientist, clinical and non-clinical bioanalysis and CRO management at Verve. Prior to joining Verve, Hongyun worked on the programming of myeloid cells for enabling coordinated immune response against cancer, both in discovery research and translational medicine at Myeloid Therapeutics. She received her Ph.D. from Rice University, where she identified the roles of tumor microenvironment derived exosomes in modulation of cancer metabolism. Hongyun then completed a research fellowship on cancer metabolism at University of Michigan. She then joined Massachusetts General Hospital as a research fellow to study the roles of myeloid-derived suppressor cells in tumor microenvironment.